{"Symbol": "CLSN", "AssetType": "Common Stock", "Name": "Celsion Corporation", "Description": "Celsion Corporation, an integrated development clinical stage oncology drug company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies for the treatment of cancer. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trial for treating primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Healthcare", "Industry": "Biotechnology", "Address": "997 Lenox Drive, Lawrenceville, NJ, United States, 08648", "FullTimeEmployees": "29", "FiscalYearEnd": "December", "LatestQuarter": "2020-06-30", "MarketCapitalization": "33897048", "EBITDA": "-18658324", "PERatio": "None", "PEGRatio": "0", "BookValue": "0.729", "DividendPerShare": "None", "DividendYield": "0", "EPS": "-0.399", "RevenuePerShareTTM": "0.019", "ProfitMargin": "0", "OperatingMarginTTM": "-39.3363", "ReturnOnAssetsTTM": "-0.2722", "ReturnOnEquityTTM": "-0.8819", "RevenueTTM": "500000", "GrossProfitTTM": "-12565309", "DilutedEPSTTM": "-0.733", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "6", "TrailingPE": "0", "ForwardPE": "0", "PriceToSalesRatioTTM": "52.3008", "PriceToBookRatio": "1.3865", "EVToRevenue": "38.9175", "EVToEBITDA": "0", "Beta": "2.1357", "52WeekHigh": "6.5", "52WeekLow": "0.6865", "50DayMovingAverage": "1.1842", "200DayMovingAverage": "1.731", "SharesOutstanding": "33232400", "SharesFloat": "32750178", "SharesShort": "1617102", "SharesShortPriorMonth": "1334311", "ShortRatio": "0.36", "ShortPercentOutstanding": "0.04", "ShortPercentFloat": "0.0466", "PercentInsiders": "1.288", "PercentInstitutions": "15.613", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "1:14", "LastSplitDate": "2017-05-30"}